PriceTargets.com logo

Universal Health Services - UHS Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $231.31
  • Forecasted Upside: -0.53%
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 9 Buy Ratings
  • 1 Strong Buy Ratings
$232.55 As of 10/22/2024 01:00 AM ET
▼ -1.07 (-0.46%)

This chart shows the closing price for UHS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Universal Health Services Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UHS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UHS

Analyst Price Target is $231.31
▼ -0.53% Downside Potential
This price target is based on 15 analysts offering 12 month price targets for Universal Health Services in the last 3 months. The average price target is $231.31, with a high forecast of $283.00 and a low forecast of $186.00. The average price target represents a -0.53% upside from the last price of $232.55.

This chart shows the closing price for UHS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 15 investment analysts is to moderate buy stock in Universal Health Services. This rating has held steady since June 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 10 hold ratings
  • 3 sell ratings
Ratings as of
5/1/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
7/30/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
10/28/2023
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
1/26/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
4/25/2024
  • 1 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
7/24/2024
  • 1 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
9/22/2024
  • 1 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2024

Latest Recommendations

  • 1 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/22/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$255.00 ➝ $275.00
10/16/2024TD CowenUpgradeHold ➝ Buy$220.00 ➝ $283.00
10/11/2024KeyCorpInitiated CoverageSector Weight
10/1/2024Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$219.00 ➝ $219.00
9/9/2024Royal Bank of CanadaBoost TargetSector Perform ➝ Sector Perform$189.00 ➝ $222.00
9/4/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$236.00 ➝ $274.00
8/19/2024Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$219.00 ➝ $219.00
8/14/2024UBS GroupBoost TargetBuy ➝ Buy$247.00 ➝ $267.00
7/30/2024The Goldman Sachs GroupBoost TargetBuy ➝ Buy$200.00 ➝ $229.00
7/30/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$200.00 ➝ $255.00
7/26/2024TD CowenBoost TargetHold ➝ Hold$183.00 ➝ $220.00
7/26/2024Cantor FitzgeraldUpgradeUnderweight ➝ Neutral$162.00 ➝ $219.00
7/26/2024BarclaysUpgradeEqual Weight ➝ Overweight$198.00 ➝ $256.00
7/25/2024StephensReiterated RatingEqual Weight ➝ Equal Weight$200.00 ➝ $200.00
7/25/2024Cantor FitzgeraldReiterated RatingUnderweight ➝ Underweight$162.00 ➝ $162.00
7/10/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$189.00 ➝ $198.00
7/9/2024Cantor FitzgeraldReiterated RatingUnderweight ➝ Underweight$162.00 ➝ $162.00
7/2/2024Cantor FitzgeraldReiterated RatingUnderweight ➝ Underweight$162.00 ➝ $162.00
6/26/2024Baird R WUpgradeHold ➝ Strong-Buy
6/26/2024Robert W. BairdUpgradeNeutral ➝ Outperform$198.00 ➝ $236.00
5/30/2024Baird R WUpgradeHold
5/30/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$182.00 ➝ $186.00
5/30/2024Robert W. BairdInitiated CoverageNeutral$198.00
5/20/2024UBS GroupUpgradeNeutral ➝ Buy$189.00 ➝ $226.00
5/7/2024Royal Bank of CanadaBoost TargetSector Perform ➝ Sector Perform$183.00 ➝ $189.00
4/30/2024TD CowenBoost TargetHold ➝ Hold$181.00 ➝ $183.00
4/26/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$181.00 ➝ $189.00
4/25/2024StephensReiterated RatingEqual Weight ➝ Equal Weight$185.00
4/12/2024Deutsche Bank AktiengesellschaftLower TargetBuy ➝ Buy$208.00 ➝ $203.00
4/10/2024Cantor FitzgeraldReiterated RatingUnderweight ➝ Underweight$156.00
3/28/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$195.00 ➝ $200.00
3/13/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$144.00 ➝ $182.00
3/6/2024MizuhoBoost TargetBuy ➝ Buy$175.00 ➝ $200.00
3/6/2024BarclaysInitiated CoverageEqual Weight$181.00
3/4/2024The Goldman Sachs GroupBoost TargetBuy ➝ Buy$170.00 ➝ $189.00
3/1/2024TD CowenBoost TargetMarket Perform ➝ Market Perform$140.00 ➝ $181.00
2/29/2024Cantor FitzgeraldBoost TargetUnderweight ➝ Underweight$148.00 ➝ $156.00
2/29/2024CitigroupBoost TargetBuy ➝ Buy$170.00 ➝ $193.00
2/29/2024UBS GroupBoost TargetNeutral ➝ Neutral$152.00 ➝ $177.00
1/2/2024Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$144.00 ➝ $177.00
12/11/2023The Goldman Sachs GroupUpgradeSell ➝ Buy$170.00
11/17/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$152.00 ➝ $144.00
10/20/2023Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$153.00 ➝ $139.00
9/21/2023BarclaysReiterated RatingEqual Weight ➝ Equal Weight$142.00
9/14/2023Cantor FitzgeraldReiterated RatingUnderweight ➝ Underweight$148.00
7/27/2023Credit Suisse GroupBoost Target$163.00 ➝ $169.00
7/26/2023UBS GroupBoost Target$154.00 ➝ $162.00
7/11/2023MizuhoBoost Target$150.00 ➝ $170.00
6/2/2023VNET GroupReiterated RatingAssumes
6/2/2023Bank of AmericaUpgradeNeutral ➝ Buy$163.00
5/26/2023SVB SecuritiesUpgradeMarket Perform ➝ Outperform$147.00 ➝ $170.00
5/16/2023MizuhoBoost Target$140.00 ➝ $150.00
5/8/2023888Reiterated RatingMaintains
4/27/2023VNET GroupReiterated RatingMaintains
4/27/2023888Reiterated RatingMaintains
4/27/2023Deutsche Bank AktiengesellschaftBoost Target$145.00 ➝ $155.00
4/27/2023Royal Bank of CanadaBoost Target$130.00 ➝ $152.00
4/27/2023CitigroupBoost Target$150.00 ➝ $165.00
4/27/2023Credit Suisse GroupBoost Target$153.00 ➝ $163.00
4/25/2023BarclaysUpgradeUnderweight ➝ Equal Weight$132.00 ➝ $142.00
4/20/2023Cantor FitzgeraldInitiated CoverageUnderweight$143.00
4/19/2023JPMorgan Chase & Co.Initiated CoverageNeutral$133.00
3/6/2023Deutsche Bank AktiengesellschaftLower TargetBuy$168.00 ➝ $145.00
3/6/2023Wells Fargo & CompanyLower TargetEqual Weight$154.00 ➝ $138.00
3/6/2023MizuhoLower TargetBuy$144.00 ➝ $140.00
3/3/2023Credit Suisse GroupLower TargetOutperform$157.00 ➝ $153.00
3/1/2023Royal Bank of CanadaBoost TargetSector Perform$114.00 ➝ $130.00
3/1/2023StephensLower TargetEqual Weight$155.00 ➝ $140.00
3/1/2023Wolfe ResearchDowngradeOutperform ➝ Peer Perform
2/28/2023StephensReiterated RatingEqual Weight$155.00
1/24/2023UBS GroupUpgradeSell ➝ Neutral$113.00 ➝ $167.00
1/9/2023BarclaysBoost TargetUnderweight$115.00 ➝ $132.00
1/3/2023Deutsche Bank AktiengesellschaftBoost Target$130.00 ➝ $168.00
1/3/2023Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$113.00 ➝ $154.00
12/16/2022Bank of AmericaUpgradeUnderperform ➝ Neutral$120.00 ➝ $145.00
12/14/2022MizuhoBoost TargetBuy$126.00 ➝ $144.00
11/25/2022Credit Suisse GroupBoost TargetOutperform$129.00 ➝ $157.00
11/16/2022UBS GroupBoost Target$113.00
11/2/2022MizuhoBoost TargetBuy$121.00 ➝ $126.00
10/27/2022Leerink PartnersBoost TargetMarket Perform$98.00 ➝ $114.00
9/6/2022Credit Suisse GroupLower Target$129.00
8/24/2022Leerink PartnersBoost TargetMarket Perform$111.00 ➝ $115.00
8/9/2022CowenLower Target$119.00
7/29/2022BarclaysLower Target$133.00 ➝ $115.00
7/28/2022Leerink PartnersBoost TargetMarket Perform$103.00 ➝ $111.00
7/27/2022StephensBoost TargetOutperform$110.00
7/27/2022Deutsche Bank AktiengesellschaftLower Target$160.00 ➝ $130.00
7/26/2022UBS GroupBoost Target$105.00
7/19/2022Credit Suisse GroupSet Target$135.00
7/15/2022Leerink PartnersLower TargetMarket Perform$108.00 ➝ $103.00
7/12/2022The Goldman Sachs GroupLower TargetSell$125.00 ➝ $110.00
7/6/2022BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$133.00 ➝ $90.00
7/4/2022StephensLower Target$105.00
7/1/2022Credit Suisse GroupLower TargetOutperform$156.00 ➝ $141.00
7/1/2022MizuhoLower TargetBuy$153.00 ➝ $121.00
6/30/2022Leerink PartnersLower TargetMarket Perform$132.00 ➝ $108.00
6/16/2022Loop CapitalInitiated CoverageHold$115.00
6/3/2022Credit Suisse GroupLower Target$156.00
5/3/2022MizuhoLower Target$164.00 ➝ $153.00
4/28/2022Wells Fargo & CompanyLower Target$139.00 ➝ $118.00
4/27/2022Royal Bank of CanadaLower Target$149.00 ➝ $130.00
4/27/2022Credit Suisse GroupLower Target$172.00 ➝ $158.00
3/28/2022Wells Fargo & CompanyInitiated CoverageUnderweight$139.00
3/7/2022UBS GroupBoost TargetSell$124.00 ➝ $134.00
3/3/2022MizuhoBoost TargetBuy$151.00 ➝ $164.00
3/1/2022CitigroupBoost Target$162.00 ➝ $167.00
2/28/2022Leerink PartnersBoost TargetMarket Perform$136.00 ➝ $139.00
2/27/2022Seaport Res PtnDowngradeBuy ➝ Neutral
1/7/2022Leerink PartnersBoost TargetMarket Perform$132.00 ➝ $136.00
12/21/2021BarclaysLower TargetUnderweight$160.00 ➝ $141.00
11/3/2021CitigroupLower TargetPositive ➝ Buy$188.00 ➝ $160.00
10/29/2021MizuhoLower TargetBuy$178.00 ➝ $151.00
10/27/2021Leerink PartnersLower TargetMarket Perform$140.00 ➝ $132.00
9/27/2021Leerink PartnersInitiated CoverageMarket Perform$140.00
9/23/2021UBS GroupInitiated CoverageSell$136.00
9/9/2021CowenInitiated CoverageOutperform$169.00
9/8/2021The Goldman Sachs GroupDowngradeNeutral ➝ Sell$155.00 ➝ $150.00
8/12/2021BarclaysDowngradeOverweight ➝ Underweight$170.00 ➝ $156.00
7/28/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$160.00 ➝ $185.00
7/28/2021MizuhoBoost TargetBuy$168.00 ➝ $178.00
7/28/2021CitigroupBoost TargetBuy$170.00 ➝ $188.00
7/27/2021BarclaysBoost TargetOverweight$160.00 ➝ $170.00
7/9/2021Seaport Res PtnReiterated RatingBuy
6/10/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$160.00 ➝ $165.00
5/5/2021MizuhoBoost TargetBuy$151.00 ➝ $168.00
4/28/2021Royal Bank of CanadaBoost TargetOutperform$150.00 ➝ $160.00
4/19/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$145.00 ➝ $160.00
3/14/2021JPMorgan Chase & Co.Reiterated RatingSell$115.00
3/2/2021CitigroupLower Target$162.00 ➝ $151.00
1/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$135.00 ➝ $145.00
1/5/2021Bank of AmericaDowngradeNeutral ➝ Underperform$144.00
12/18/2020MizuhoBoost TargetBuy$130.00 ➝ $151.00
12/15/2020The Goldman Sachs GroupInitiated CoverageNeutral$149.00
11/11/2020Piper SandlerBoost TargetNeutral$117.00 ➝ $139.00
11/2/2020Credit Suisse GroupBoost TargetOutperform$140.00 ➝ $145.00
9/21/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$138.00 ➝ $115.00
7/30/2020Royal Bank of CanadaReiterated RatingBuy
7/29/2020Piper SandlerBoost TargetNeutral$113.00 ➝ $117.00
7/29/2020Credit Suisse GroupBoost TargetOutperform$139.00 ➝ $140.00
6/9/2020BarclaysUpgradeEqual Weight ➝ Overweight$138.00
5/29/2020MizuhoLower TargetBuy$136.00 ➝ $130.00
4/30/2020Royal Bank of CanadaReiterated RatingBuy
4/30/2020UBS GroupLower TargetBuy$150.00 ➝ $133.00
4/29/2020Deutsche Bank AktiengesellschaftLower TargetBuy$165.00 ➝ $135.00
4/28/2020CitigroupLower TargetBuy$157.00 ➝ $128.00
4/23/2020Piper SandlerLower TargetNeutral$141.00 ➝ $113.00
3/23/2020Bank of AmericaDowngradeBuy ➝ Neutral$182.00 ➝ $104.00
3/2/2020JPMorgan Chase & Co.Lower TargetNeutral$164.00 ➝ $155.00
2/28/2020Robert W. BairdBoost TargetOutperform$160.00 ➝ $165.00
2/28/2020UBS GroupLower TargetBuy$158.00 ➝ $150.00
2/28/2020StephensLower TargetEqual Weight$153.00 ➝ $151.00
2/28/2020BarclaysReiterated RatingHold$145.00
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$140.00
12/20/2019JPMorgan Chase & Co.Boost TargetNeutral$159.00 ➝ $164.00
(Data available from 10/23/2019 forward)

News Sentiment Rating

0.81 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 21 very positive mentions
  • 20 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/27/2024
  • 11 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/26/2024
  • 23 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/26/2024
  • 17 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/25/2024
  • 17 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/25/2024
  • 31 very positive mentions
  • 27 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/24/2024
  • 18 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/23/2024
  • 27 very positive mentions
  • 24 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
10/23/2024

Current Sentiment

  • 27 very positive mentions
  • 24 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Universal Health Services logo
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. It also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Read More

Today's Range

Now: $232.55
Low: $229.53
High: $234.44

50 Day Range

MA: $229.75
Low: $212.52
High: $241.52

52 Week Range

Now: $232.55
Low: $119.90
High: $243.25

Volume

606,518 shs

Average Volume

665,415 shs

Market Capitalization

$15.56 billion

P/E Ratio

17.05

Dividend Yield

0.34%

Beta

1.27

Frequently Asked Questions

What sell-side analysts currently cover shares of Universal Health Services?

The following equities research analysts have issued research reports on Universal Health Services in the last twelve months: Baird R W, Barclays PLC, Cantor Fitzgerald, Citigroup Inc., Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., KeyCorp, Mizuho, Robert W. Baird, Royal Bank of Canada, Stephens, StockNews.com, TD Cowen, The Goldman Sachs Group, Inc., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for UHS.

What is the current price target for Universal Health Services?

13 Wall Street analysts have set twelve-month price targets for Universal Health Services in the last year. Their average twelve-month price target is $231.31, suggesting a possible downside of 0.5%. TD Cowen has the highest price target set, predicting UHS will reach $283.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $186.00 for Universal Health Services in the next year.
View the latest price targets for UHS.

What is the current consensus analyst rating for Universal Health Services?

Universal Health Services currently has 5 hold ratings, 9 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for UHS.

What other companies compete with Universal Health Services?

Other companies that are similar to Universal Health Services include Alcon, Tenet Healthcare, Encompass Health, The Ensign Group and Acadia Healthcare. Learn More about companies similar to Universal Health Services.

How do I contact Universal Health Services' investor relations team?

Universal Health Services' physical mailing address is 367 S GULPH RD, KING OF PRUSSIA PA, 19406. The health services provider's listed phone number is (610) 768-3300 and its investor relations email address is [email protected]. The official website for Universal Health Services is www.uhsinc.com. Learn More about contacing Universal Health Services investor relations.